Theravance Biopharma (TBPH) Tax Provisions (2014 - 2026)
Theravance Biopharma's (TBPH) quarterly Tax Provisions came in at -$1.5 million in Q1 2026, down 168.34% year-on-year from $2.2 million in Q1 2025, and down 106.37% on a QoQ basis from $23.6 million in Q4 2025.
Theravance Biopharma (TBPH) Tax Provisions (2014 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has 13 years of Tax Provisions data on file, last reported at -$1.5 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 168.34% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was $33.9 million, a 239.88% increase from a year earlier, with the FY2025 full-year figure at $34.9 million, up 195.42% from the prior year.
- Tax Provisions for Q1 2026 stood at -$1.5 million, down from $23.6 million in the prior quarter.
- Over the last five years, Tax Provisions for TBPH reached as high as $23.6 million in Q4 2025 and fell as low as -$6.5 million in Q3 2025.
- Historically, Tax Provisions has averaged $2.8 million across 5 years, with a median of $524000.0 in 2022.
- Across the five-year window, Tax Provisions plunged 7142.86% in 2022 and surged 29260.0% in 2023, its largest moves.
- Year by year, Tax Provisions stood at -$3000.0 in 2022, then soared by 9666.67% to $287000.0 in 2023, then soared by 2195.47% to $6.6 million in 2024, then soared by 257.67% to $23.6 million in 2025, then sank by 106.37% to -$1.5 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were -$1.5 million in Q1 2026, $23.6 million in Q4 2025, and -$6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | 23.56 Mn |
| Sep 30, 2025 | -6.50 Mn |
| Jun 30, 2025 | 18.37 Mn |
| Mar 31, 2025 | -559,000.00 |
| Dec 31, 2024 | 6.59 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | -395,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -507,000.00 |
| Jun 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 524,000.00 |
| Dec 31, 2021 | -200,000.00 |
| Sep 30, 2021 | -7,000.00 |
| Jun 30, 2021 | -220,000.00 |